Inhaled mometasone furoate reduces oral prednisone requirements while improving respiratory function and health-related quality of life in patients with severe persistent asthma.
Fish JE, Karpel JP, Craig TJ, Bensch GW, Noonan M, Webb DR, Silverman B, Schenkel EJ, Rooklin AR, Ramsdell JW, Nathan R, Leflein JG, Grossman J, Graft DF, Gower RG, Garay SM, Frigas E, Degraff AC, Bronsky EA, Bernstein DI, Berger W, Shneyer L, Nolop KB, Harrison JE.
Fish JE, et al. Among authors: webb dr.
J Allergy Clin Immunol. 2000 Nov;106(5):852-60. doi: 10.1067/mai.2000.110798.
J Allergy Clin Immunol. 2000.
PMID: 11080706
Clinical Trial.